article · Current Pharmaceutical Biotechnology
INTRODUCTION: Industrial expansion increases human exposure to Cadmium (Cd), a heavy metal that accumulates in the kidneys, causing tubular injury and chronic kidney disease. This study evaluates the chelating effects of meso-2,3-dimercaptosuccinic acid (DMSA) and spirulina's protective role against Cd-induced nephrotoxicity in rats. METHODS: Forty male Sprague-Dawley rats (6-7 weeks old, 200-250 g) were randomly divided into five groups (n = 8/group): (1) Control group received distilled water; (2) Cd group received cadmium chloride (5 mg/kg body weight) orally, three times/week for 6 weeks; (3) Cd + DMSA group received DMSA (50 mg/kg) orally, daily for 2 weeks following Cd exposure; (4) Spirulina treatment group received spirulina (1 g/kg) orally, daily alongside Cd; (5) Spirulina protection group received spirulina 2 weeks before and throughout Cd exposure. Renal function markers, oxidative stress indicators (8-OHdG, isoprostane, MDA), antioxidant enzymes (GSH, SOD, CAT), and gene expression of inflammatory (TNF-α, NF-κB), apoptotic (Bax), anti-apoptotic (BCL-2), and detoxification (MT1) markers were assessed. Data were analyzed using one-way ANOVA followed by Tukey's post hoc test, with significance set at p < 0.05. RESULTS: Cd exposure significantly impaired renal function, increased oxidative stress, and upregulated pro-inflammatory and apoptotic markers (p < 0.05). Both DMSA and spirulina significantly mitigated these effects, with prophylactic spirulina showing the most significant improvements. DISCUSSION: Administering DMSA and spirulina effectively mitigates Cd-induced nephrotoxicity and helps restore normal kidney function. CONCLUSION: Spirulina and DMSA demonstrate protective effects against cadmium-induced nephrotoxicity. Spirulina, particularly when used prophylactically, potentially offering superior renal protection.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.2174/0113892010429980251223102626
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.